Johnson & Johnson CEO Gorsky Reaffirms Diversified Strategy
This article was originally published in The Gray Sheet
Executive Summary
Faced with spin-off models from other diversified health care firms, including Abbott and Pfizer, Gorsky defended J&J’s broader-based approach as a better long-term strategy.